HMA/EMA multi-stakeholder workshop on shortages
Event
Human
Medicine shortages
Date
Location
The aims of the EMA and HMA workshop on the activities on medicine shortages and initiatives are to:
HMA/EMA Task Force was established by EU regulators in 2016 to develop and coordinate actions for better prevention, identification, management of and communication on issues that can affect the availability of medicines, in order to improve continuity of supply of human and veterinary medicines across Europe.
Day 1:
Session 1: Setting the scene
Breakout session 2A: Immunoglobulins
Breakout session 2B: Biosimilars
Breakout session 2C: Medicines for veterinary use
Day 2:
Welcome and summary of day 1
Session 3: Prevention of shortages
Session 4: Permanent withdrawals from the market
Session 5: Communication and transparency
Session 6: Work ahead to 2025